Smoking Resumption After Heart or Lung Transplantation: a Systematic Review and Suggestions for Screening and Management

Overview

Journal J Thorac Dis

Publisher AME Publishing Company

Specialty Pulmonary Medicine

Date 2018 Sep 4

PMID 30174913

Citations 8

Authors

Patrick Hofmann

Christian Benden

Malcolm Kohler

Mace M Schuurmans

Affiliations

Soon will be listed here.

Abstract

Smoking remains the leading cause of preventable disease and death in the developed world and kills half of all long-term users. Smoking resumption after heart or lung transplantation is associated with allograft dysfunction, higher incidence of cancer, and reduced overall survival. Although self-reporting is considered an unreliable method for tobacco use detection, implementing systematic cotinine-based screening has proven challenging. This review examines the prevalence of smoking resumption in thoracic transplant patients, explores the risk factors associated with a post-transplant smoking resumption and discusses the currently available smoking cessation interventions for transplant patients.

Citing Articles

Smoking Mechanics and Impact on Smoking Cessation: Two Cases of Smoking Lapse Status Post Lung Transplantation.

Galiatsatos P, Ekpo P, Schreiber R, Barker L, Shah P Tob Use Insights. 2022; 15:1179173X211069634.

PMID: 35023981 PMC: 8744156. DOI: 10.1177/1179173X211069634.

Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation.

Leard L, Holm A, Valapour M, Glanville A, Attawar S, Aversa M J Heart Lung Transplant. 2021; 40(11):1349-1379.

PMID: 34419372 PMC: 8979471. DOI: 10.1016/j.healun.2021.07.005.

Recurrence of emphysema post-lung transplantation in a patient with alpha 1 antitrypsin deficiency (AATD).

Ataya A Respir Med Case Rep. 2020; 31:101309.

PMID: 33304809 PMC: 7718162. DOI: 10.1016/j.rmcr.2020.101309.

History of cigarette smoking and heart transplant outcomes.

Ohiomoba R, Youmans Q, Akanyirige P, Ezema A, Anderson A, Bryant A Int J Cardiol Heart Vasc. 2020; 30:100599.

PMID: 32775604 PMC: 7398935. DOI: 10.1016/j.ijcha.2020.100599.

High prevalence of falsely declaring nicotine abstinence in lung transplant candidates.

Veit T, Munker D, Leuschner G, Mummler C, Sisic A, Kauke T PLoS One. 2020; 15(6):e0234808.

PMID: 32555678 PMC: 7302701. DOI: 10.1371/journal.pone.0234808.

References

Evangelista L, Ter-Galstanyan A, Moser D, Dracup K . Smoking among women following heart transplantation: should we be concerned?. Prog Cardiovasc Nurs. 2009; 24(4):119-23. PMC: 2892715. DOI: 10.1111/j.1751-7117.2009.00049.x. View

. Biochemical verification of tobacco use and cessation. Nicotine Tob Res. 2002; 4(2):149-59. DOI: 10.1080/14622200210123581. View

Jorenby D, Hays J, Rigotti N, Azoulay S, Watsky E, Williams K . Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA. 2006; 296(1):56-63. DOI: 10.1001/jama.296.1.56. View

de Geest S, Dobbels F, Fluri C, Paris W, Troosters T . Adherence to the therapeutic regimen in heart, lung, and heart-lung transplant recipients. J Cardiovasc Nurs. 2005; 20(5 Suppl):S88-98. DOI: 10.1097/00005082-200509001-00010. View

Stine J, Chalasani N . Chronic liver injury induced by drugs: a systematic review. Liver Int. 2015; 35(11):2343-53. DOI: 10.1111/liv.12958. View

Stead L, Hartmann-Boyce J, Perera R, Lancaster T . Telephone counselling for smoking cessation. Cochrane Database Syst Rev. 2013; (8):CD002850. DOI: 10.1002/14651858.CD002850.pub3. View

Stitzer M, Bigelow G . Contingent reinforcement for reduced carbon monoxide levels in cigarette smokers. Addict Behav. 1982; 7(4):403-12. DOI: 10.1016/0306-4603(82)90010-7. View

Lindson-Hawley N, Thompson T, Begh R . Motivational interviewing for smoking cessation. Cochrane Database Syst Rev. 2015; (3):CD006936. DOI: 10.1002/14651858.CD006936.pub3. View

Costanzo M, Eisen H, Brown R, Mehra M, Benza R, Torre G . Are there specific risk factors for fatal allograft vasculopathy? An analysis of over 7,000 cardiac transplant patients. J Heart Lung Transplant. 2001; 20(2):152. DOI: 10.1016/s1053-2498(00)00261-8. View

10.

Anthenelli R, Benowitz N, West R, Aubin L, McRae T, Lawrence D . Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. Lancet. 2016; 387(10037):2507-20. DOI: 10.1016/S0140-6736(16)30272-0. View

11.

Basile A, Bernazzali S, Diciolla F, Lenzini F, Lisi G, Maccherini M . Risk factors for smoking abuse after heart transplantation. Transplant Proc. 2004; 36(3):641-2. DOI: 10.1016/j.transproceed.2004.02.054. View

12.

Wilkes S . The use of bupropion SR in cigarette smoking cessation. Int J Chron Obstruct Pulmon Dis. 2008; 3(1):45-53. PMC: 2528204. DOI: 10.2147/copd.s1121. View

13.

Bilano V, Gilmour S, Moffiet T, Tursan dEspaignet E, Stevens G, Commar A . Global trends and projections for tobacco use, 1990-2025: an analysis of smoking indicators from the WHO Comprehensive Information Systems for Tobacco Control. Lancet. 2015; 385(9972):966-76. DOI: 10.1016/S0140-6736(15)60264-1. View

14.

Barboza J, Patel R, Patel P, Hudmon K . An update on the pharmacotherapeutic interventions for smoking cessation. Expert Opin Pharmacother. 2016; 17(11):1483-96. DOI: 10.1080/14656566.2016.1197203. View

15.

Ruttens D, Verleden S, Goeminne P, Poels K, Vandermeulen E, Godderis L . Smoking resumption after lung transplantation: standardised screening and importance for long-term outcome. Eur Respir J. 2013; 43(1):300-3. DOI: 10.1183/09031936.00141113. View

16.

Parisi G, Di Dio G, Franzonello C, Gennaro A, Rotolo N, Lionetti E . Liver disease in cystic fibrosis: an update. Hepat Mon. 2013; 13(8):e11215. PMC: 3810678. DOI: 10.5812/hepatmon.11215. View

17.

Mehra M, Uber P, Prasad A, Scott R, Park M . Recrudescent tobacco exposure following heart transplantation: clinical profiles and relationship with athero-thrombosis risk markers. Am J Transplant. 2005; 5(5):1137-40. DOI: 10.1111/j.1600-6143.2005.00809.x. View

18.

Lewis B, Aoun S, Bernstein G, Crow S . Pharmacokinetic interactions between cyclosporine and bupropion or methylphenidate. J Child Adolesc Psychopharmacol. 2001; 11(2):193-8. DOI: 10.1089/104454601750284117. View

19.

Choi Y, Leung A, Miro S, Poirier C, Hunt S, Theodore J . Primary bronchogenic carcinoma after heart or lung transplantation: radiologic and clinical findings. J Thorac Imaging. 2000; 15(1):36-40. DOI: 10.1097/00005382-200001000-00008. View

20.

Reeb J, Keshavjee S, Cypel M . Expanding the lung donor pool: advancements and emerging pathways. Curr Opin Organ Transplant. 2015; 20(5):498-505. DOI: 10.1097/MOT.0000000000000233. View